Corrigendum to "Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I
κ
B
α
/NF
κ
B and Enhancing Nrf2/HO-1"
Oxid Med Cell Longev
.
2021 May 4:2021:9812928.
doi: 10.1155/2021/9812928.
eCollection 2021.
Authors
Hai-Han Liao
1
2
3
,
Jin-Xiu Zhu
1
2
3
,
Hong Feng
4
,
Jian Ni
1
2
3
,
Nan Zhang
1
2
3
,
Si Chen
2
3
,
Huang-Jun Liu
1
2
3
,
Zheng Yang
1
2
3
,
Wei Deng
1
2
3
,
Qi-Zhu Tang
1
2
3
Affiliations
1
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
2
Cardiovascular Research Institute of Wuhan University, Wuhan, China.
3
Hubei Key Laboratory of Cardiology, Wuhan, China.
4
Department of Gerontology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
PMID:
34055200
PMCID:
PMC8112953
DOI:
10.1155/2021/9812928
Abstract
[This corrects the article DOI: 10.1155/2017/8370593.].
Copyright © 2021 Hai-han Liao et al.
Publication types
Published Erratum